G YAO

608 total citations
24 papers, 443 citations indexed

About

G YAO is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, G YAO has authored 24 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 7 papers in Oncology. Recurrent topics in G YAO's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Cancer Immunotherapy and Biomarkers (5 papers). G YAO is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Cancer Immunotherapy and Biomarkers (5 papers). G YAO collaborates with scholars based in China, Canada and United Kingdom. G YAO's co-authors include Phoebe Lindsey Barton, A Fry-Smith, Fujian Song, Wutao Lou, Montserrat Cruzado, Yudong Yao, Ernesto L. Schiffrin, Roberto Miatello, Shi Yao and Rhian M. Touyz and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

G YAO

24 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G YAO China 8 136 119 104 89 64 24 443
Sung Jae Park South Korea 13 93 0.7× 86 0.7× 83 0.8× 8 0.1× 15 0.2× 52 443
Stefania Manganelli Italy 12 72 0.5× 46 0.4× 37 0.4× 17 0.2× 34 0.5× 19 485
Qiu Li China 13 29 0.2× 15 0.1× 104 1.0× 48 0.5× 56 0.9× 39 408
Hongbing Yao China 13 86 0.6× 53 0.4× 231 2.2× 13 0.1× 22 0.3× 50 635
Lee Jk Taiwan 10 49 0.4× 17 0.1× 29 0.3× 25 0.3× 7 0.1× 65 328
Toshiya Nishikubo Japan 10 22 0.2× 13 0.1× 100 1.0× 72 0.8× 21 0.3× 35 354
Takako Matsubara Japan 10 72 0.5× 78 0.7× 49 0.5× 14 0.2× 7 0.1× 28 283
Paul Griffiths United Kingdom 13 49 0.4× 32 0.3× 118 1.1× 15 0.2× 20 0.3× 33 510
Cengiz Dilber Türkiye 10 40 0.3× 18 0.2× 46 0.4× 25 0.3× 14 0.2× 35 256
Chang‐Nam Son South Korea 12 38 0.3× 17 0.1× 83 0.8× 17 0.2× 8 0.1× 51 429

Countries citing papers authored by G YAO

Since Specialization
Citations

This map shows the geographic impact of G YAO's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G YAO with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G YAO more than expected).

Fields of papers citing papers by G YAO

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G YAO. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G YAO. The network helps show where G YAO may publish in the future.

Co-authorship network of co-authors of G YAO

This figure shows the co-authorship network connecting the top 25 collaborators of G YAO. A scholar is included among the top collaborators of G YAO based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G YAO. G YAO is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Zihao, Xinyan Chen, Yuhang Chen, et al.. (2025). Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy. Frontiers in Immunology. 16. 1557461–1557461. 2 indexed citations
2.
Dai, Lei, G YAO, Zhiping Tan, et al.. (2025). Using machine learning for predicting cancer-specific mortality in bladder cancer patients undergoing radical cystectomy: a SEER-based study. BMC Cancer. 25(1). 523–523. 1 indexed citations
3.
YAO, G, Liangmin Fu, Jinwei Chen, et al.. (2024). Exploring the oncogenic potential of circSOD2 in clear cell renal cell carcinoma: a novel positive feedback loop. Journal of Translational Medicine. 22(1). 596–596. 1 indexed citations
4.
YAO, G, Zhiping Tan, Yinghan Wang, et al.. (2023). A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma. Frontiers in Pharmacology. 14. 1120562–1120562. 1 indexed citations
5.
Cao, Jiazheng, G YAO, Fei Liu, et al.. (2022). TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types. Aging. 14(6). 2868–2879. 2 indexed citations
6.
7.
Gui, Chengpeng, Bing Liao, Yuhang Chen, et al.. (2021). circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis. Molecular Cancer. 20(1). 169–169. 39 indexed citations
8.
Ji, Yaohua, et al.. (2013). Two years efficiency of lamivudine and adefovir dipivoxil combined therapy in chronic hepatitis B patients.. PubMed. 17(5). 636–43. 3 indexed citations
9.
10.
Zhang, Lin, Jia Huang, Nuo Yang, et al.. (2007). MICRORNAS EXHIBIT HIGH FREQUENCY GENO-MIC ALTERATIONS IN HUMAN OVARIAN CANCER. Biology of Reproduction. 77(Suppl_1). 66–66. 1 indexed citations
11.
Zeng, Ming, et al.. (2006). 496 Efficacy and safety of 2 years adefovir dipivoxil (ADV) in chinese patients with HBeAg positive chronic hepatitis B (CHB). Journal of Hepatology. 44. S185–S185. 1 indexed citations
12.
13.
Touyz, Rhian M., G YAO, & Ernesto L. Schiffrin. (2005). Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells. American Journal of Hypertension. 18(5). A237–A237. 2 indexed citations
14.
Song, Fujian, et al.. (2003). Screening for fragile X syndrome: a literature review and modelling study. Health Technology Assessment. 7(16). 1–106. 94 indexed citations
15.
Sylvan, Staffan, et al.. (1999). IgG antibodies to synthetic peptides mimicking B-cell epitopes within the hepatitis B virus (HBV) envelope preS2 region protein: Relation to viremia and liver-disease activity in chronic HBV infection. Central European Journal of Immunology. 24(4). 248–256. 1 indexed citations
16.
17.
YAO, G, et al.. (1999). A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.. PubMed. 112(5). 387–91. 18 indexed citations
18.
YAO, G. (1996). Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China.. Gut. 38(Suppl 2). S39–S42. 91 indexed citations
19.
Yao, Yudong, et al.. (1992). Prevalence of vitamin B12 deficiency among geriatric outpatients.. PubMed. 35(5). 524–8. 61 indexed citations
20.
Sylvan, Staffan, et al.. (1991). IgM anti‐preS2 monitoring during combined corticosteroid/interferon‐alpha 2b therapy in chronic hepatitis B. Liver International. 11(6). 358–364. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung Jae Park Breakdown of academic impact, for papers by Stefania Manganelli Breakdown of academic impact, for papers by Qiu Li Breakdown of academic impact, for papers by Hongbing Yao Breakdown of academic impact, for papers by Lee Jk Breakdown of academic impact, for papers by Toshiya Nishikubo Breakdown of academic impact, for papers by Takako Matsubara Breakdown of academic impact, for papers by Paul Griffiths Breakdown of academic impact, for papers by Cengiz Dilber Breakdown of academic impact, for papers by Chang‐Nam Son
Rankless by CCL
2026